27
Alger Life Sciences Innovation Fund LP updates its Form D — $30.3M sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $30.3M · NEW YORK, NY · filed 2026-04-10
3(c)(7) — qualified purchasers
27
Alger Life Sciences Innovation Fund LP updates its Form D — $17.3M sold
Fund raise update · Hedge fund · Open-ended · NEW YORK, NY · Form D/A filed 2025-04-11 · all Alger Life Sciences vehicles
3(c)(7) — qualified purchasers
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| Hal Cayley Liebes | Executive Officer, Director |
| Robert Louis Kincel | Executive Officer, Director |
| N/A Alger Alternative Holdings II, LLC | General Partner of the Issuer |
| N/A Fred Alger Management, LLC | Investment Manager of the Issuer |
| Daniel Cayley Chung | Executive Officer, Director |
Signed by Hal Liebes, COO of Sole Member of GP of Issuer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.